If you mean ones that have only been introduced here recently, then no, I don't think so. But if you mean "of any that have shown up here in the past year or so" . . . ACHN, FGEN (well, maybe not a 10 bagger, since it's already tripled over the last year, but FGEN could still do multiples of its current MC if things go well, same goes for BPMC), VKTX (especially if MDGL stumbles somehow, but it's not seen as a class effect), PIRS. I have long positions via stock or options in all of these except VKTX. From a bit further back (2016), TRIL, which seems undervalued versus recent IPOs going for the same target. Not currently long that one, but watching. Of these, ACHN, PIRS, VKTX, and TRIL probably have the most potential, but that goes with substantially more risk than say, FGEN, because their programs are early stage. As the saying goes, do your DD, this isn't investment advice, blah blah.
I probably missed REGN from the prior list.
Cheers, Tuck |
